Skip to main content
Equibles

ExodusPoint Capital Management, LP

Position in MYGN — Myriad Genetics Inc

CIK 1736225 NEW YORK, NY
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,211,542
-$715,683 QoQ
Shares Held
212,179
-32.3% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 196 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $101,462,417 across 18 Diagnostics & Research names. MYGN ranks #12 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 164,518 $24,682,635
2 TMO
Thermo Fisher Scientific Inc.
 32,661 $16,374,918
3 QGEN
Qiagen N.V.
 321,161 $12,557,395
4 A
Agilent Technologies, Inc.
 68,639 $9,117,318
5 DHR
Danaher Corp /De/
 45,615 $8,688,745
6 IDXX
Idexx Laboratories Inc /De
 12,971 $6,828,453
7 CDNA
CareDx, Inc.
 214,342 $6,108,747
8 VCYT
Veracyte, Inc.
 94,044 $5,523,204

All Filings in MYGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,211,542 212,179
2025-12-31 $1,927,225 313,370
2025-09-30 $155,734 21,540
2025-06-30 $327,542 61,684
2025-03-31 $1,318,906 148,693
2024-06-30 $4,165,220 170,287
2024-03-31 $1,685,687 79,066
2023-09-30 $288,078 17,960
2023-06-30 $8,382,282 361,617
2022-12-31 $178,473 12,300
2020-12-31 $463,349 23,437
2020-06-30 $417,754 36,839